Elevance Health, Inc. (FRA:A58)
Germany · Delayed Price · Currency is EUR 289.80
+5.20 (1.83%)
At close: Jan 30, 2026
Elevance Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Depreciation & Amortization | 1,546 | 659 | 1,060 | 1,076 | 817 |
Other Amortization | - | 734 | 685 | 599 | 485 |
Gain (Loss) on Sale of Assets | - | -201 | - | - | - |
Stock-Based Compensation | 276 | 191 | 289 | 264 | 255 |
Change in Accounts Receivable | - | -683 | -1,762 | -2,510 | -2,138 |
Change in Accounts Payable | - | -272 | 1,640 | 824 | 719 |
Change in Unearned Revenue | - | -113 | 290 | -42 | -113 |
Change in Income Taxes | - | 404 | -103 | -338 | 140 |
Change in Insurance Reserves / Liabilities | - | -1,840 | 147 | 2,411 | 2,523 |
Change in Other Net Operating Assets | -3,680 | 785 | -747 | 78 | -8 |
Other Operating Activities | 486 | 62 | 96 | 429 | 15 |
Operating Cash Flow | 4,290 | 5,808 | 8,061 | 8,399 | 8,364 |
Operating Cash Flow Growth | -26.14% | -27.95% | -4.02% | 0.42% | -21.74% |
Capital Expenditures | -1,116 | -1,256 | -1,296 | -1,152 | -1,087 |
Cash Acquisitions | 88 | -4,809 | -1,552 | -649 | -3,476 |
Investment in Securities | 69 | 586 | -2,700 | -2,338 | -4,056 |
Other Investing Activities | -385 | -51 | -24 | -421 | -1,019 |
Investing Cash Flow | -1,344 | -5,167 | -5,572 | -4,560 | -9,638 |
Short-Term Debt Issued | - | 275 | 339 | 2,298 | 2,331 |
Long-Term Debt Issued | 629 | 7,710 | 2,574 | 3,373 | 3,462 |
Total Debt Issued | 629 | 7,985 | 2,913 | 5,671 | 5,793 |
Total Debt Repaid | - | -2,498 | -2,251 | -3,574 | -2,494 |
Net Debt Issued (Repaid) | 629 | 5,487 | 662 | 2,097 | 3,299 |
Issuance of Common Stock | - | 221 | 152 | 182 | 203 |
Repurchases of Common Stock | -2,605 | -3,009 | -2,775 | -2,409 | -2,002 |
Common Dividends Paid | -1,529 | -1,508 | -1,395 | -1,229 | -1,104 |
Other Financing Activities | 1,767 | 2 | 7 | 41 | 27 |
Financing Cash Flow | -1,738 | 1,193 | -3,349 | -1,318 | 423 |
Foreign Exchange Rate Adjustments | -5 | -6 | -1 | -14 | -10 |
Miscellaneous Cash Flow Adjustments | - | -66 | - | - | - |
Net Cash Flow | 1,203 | 1,762 | -861 | 2,507 | -861 |
Free Cash Flow | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 |
Free Cash Flow Growth | -30.27% | -32.71% | -6.65% | -0.41% | -24.72% |
Free Cash Flow Margin | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% |
Free Cash Flow Per Share | 14.13 | 19.55 | 28.50 | 29.85 | 29.48 |
Cash Interest Paid | - | 1,239 | 1,032 | 878 | 822 |
Cash Income Tax Paid | - | 1,303 | 1,936 | 1,594 | 1,299 |
Levered Free Cash Flow | 3,555 | 6,846 | 3,005 | 8,425 | 3,614 |
Unlevered Free Cash Flow | 4,431 | 7,586 | 3,649 | 8,960 | 4,115 |
Change in Working Capital | -3,680 | -1,719 | -535 | 423 | 1,123 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.